11-ketotestosterone has been researched along with Polycystic Ovarian Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arlt, W; Jenkinson, C; Kempegowda, P; O'Reilly, MW; Quanson, JL; Storbeck, KH; Taylor, AE | 1 |
Auchus, RJ; Turcu, AF | 1 |
2 other study(ies) available for 11-ketotestosterone and Polycystic Ovarian Syndrome
Article | Year |
---|---|
11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.
Topics: Adult; Androgens; Androstenedione; Androstenes; Blood Glucose; Case-Control Studies; Chromatography, Liquid; Dehydroepiandrosterone; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydroxytestosterones; Hyperandrogenism; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Tandem Mass Spectrometry; Testosterone; Young Adult | 2017 |
Clinical significance of 11-oxygenated androgens.
Topics: Adrenal Hyperplasia, Congenital; Biomarkers; Diagnostic Techniques, Endocrine; Female; Humans; Male; Patient-Centered Care; Polycystic Ovary Syndrome; Precision Medicine; Predictive Value of Tests; Prostatic Neoplasms; Testosterone | 2017 |